

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of erythrocyte differentiation (GO:0045647) | 6.55066674 |
| 2 | positive regulation of B cell differentiation (GO:0045579) | 5.16550764 |
| 3 | response to peptidoglycan (GO:0032494) | 4.95414157 |
| 4 | neutrophil activation involved in immune response (GO:0002283) | 4.95176023 |
| 5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.77321331 |
| 6 | immunoglobulin mediated immune response (GO:0016064) | 4.60984024 |
| 7 | regulation of mast cell degranulation (GO:0043304) | 4.11923074 |
| 8 | pinocytosis (GO:0006907) | 4.03489656 |
| 9 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.99659875 |
| 10 | cellular response to exogenous dsRNA (GO:0071360) | 3.97286502 |
| 11 | regulation of leukocyte degranulation (GO:0043300) | 3.93681548 |
| 12 | response to muramyl dipeptide (GO:0032495) | 3.87560422 |
| 13 | negative regulation of interleukin-12 production (GO:0032695) | 3.85985271 |
| 14 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.85787984 |
| 15 | macrophage differentiation (GO:0030225) | 3.81966551 |
| 16 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.74175795 |
| 17 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.71260720 |
| 18 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.58701088 |
| 19 | regulation of B cell differentiation (GO:0045577) | 3.55570401 |
| 20 | mannose metabolic process (GO:0006013) | 3.45349551 |
| 21 | B cell mediated immunity (GO:0019724) | 3.41720276 |
| 22 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.41029239 |
| 23 | mature B cell differentiation involved in immune response (GO:0002313) | 3.36632466 |
| 24 | response to thyroid hormone (GO:0097066) | 3.27870303 |
| 25 | positive regulation by symbiont of host defense response (GO:0052509) | 3.21206674 |
| 26 | modulation by symbiont of host defense response (GO:0052031) | 3.21206674 |
| 27 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.21206674 |
| 28 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.21206674 |
| 29 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.21206674 |
| 30 | modulation by symbiont of host immune response (GO:0052553) | 3.21206674 |
| 31 | regulation of gamma-delta T cell activation (GO:0046643) | 3.20275040 |
| 32 | glycosphingolipid catabolic process (GO:0046479) | 3.19528891 |
| 33 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.18762521 |
| 34 | negative regulation of granulocyte differentiation (GO:0030853) | 3.15531726 |
| 35 | neutrophil activation (GO:0042119) | 3.14361764 |
| 36 | regulation of hypersensitivity (GO:0002883) | 3.11988427 |
| 37 | negative regulation of interleukin-6 production (GO:0032715) | 3.10672156 |
| 38 | granulocyte activation (GO:0036230) | 3.09660558 |
| 39 | regulation of regulated secretory pathway (GO:1903305) | 3.09366234 |
| 40 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.09325292 |
| 41 | detection of bacterium (GO:0016045) | 3.06466436 |
| 42 | detection of other organism (GO:0098543) | 3.06353527 |
| 43 | regulation of mast cell activation (GO:0033003) | 3.03228304 |
| 44 | regulation of vitamin metabolic process (GO:0030656) | 3.01104925 |
| 45 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.00518775 |
| 46 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.00046640 |
| 47 | positive regulation of mast cell degranulation (GO:0043306) | 3.00046640 |
| 48 | regulation of female gonad development (GO:2000194) | 2.99469151 |
| 49 | regulation of antigen processing and presentation (GO:0002577) | 2.98410493 |
| 50 | myeloid cell activation involved in immune response (GO:0002275) | 2.97015258 |
| 51 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.96598876 |
| 52 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.93886754 |
| 53 | positive regulation of antigen processing and presentation (GO:0002579) | 2.91976384 |
| 54 | macrophage activation involved in immune response (GO:0002281) | 2.91394662 |
| 55 | response to protozoan (GO:0001562) | 2.90804548 |
| 56 | NIK/NF-kappaB signaling (GO:0038061) | 2.90598108 |
| 57 | glycolipid catabolic process (GO:0019377) | 2.89354493 |
| 58 | reactive oxygen species biosynthetic process (GO:1903409) | 2.88172998 |
| 59 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.86891693 |
| 60 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.86436086 |
| 61 | Peyers patch development (GO:0048541) | 2.86436086 |
| 62 | negative regulation of interleukin-8 production (GO:0032717) | 2.86312472 |
| 63 | germinal center formation (GO:0002467) | 2.83224880 |
| 64 | definitive hemopoiesis (GO:0060216) | 2.82825376 |
| 65 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.81933779 |
| 66 | respiratory burst (GO:0045730) | 2.80269902 |
| 67 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.74027207 |
| 68 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.74027207 |
| 69 | regulation of growth of symbiont in host (GO:0044126) | 2.74027207 |
| 70 | negative regulation of growth of symbiont in host (GO:0044130) | 2.74027207 |
| 71 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.72888808 |
| 72 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.72276865 |
| 73 | regulation of B cell apoptotic process (GO:0002902) | 2.72103070 |
| 74 | regulation of erythrocyte differentiation (GO:0045646) | 2.71188810 |
| 75 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.68892893 |
| 76 | response to hydroperoxide (GO:0033194) | 2.68433147 |
| 77 | positive regulation of megakaryocyte differentiation (GO:0045654) | 2.68195576 |
| 78 | B cell receptor signaling pathway (GO:0050853) | 2.67899217 |
| 79 | positive thymic T cell selection (GO:0045059) | 2.66824922 |
| 80 | regulation of tumor necrosis factor superfamily cytokine production (GO:1903555) | 2.63182086 |
| 81 | barbed-end actin filament capping (GO:0051016) | 2.62448072 |
| 82 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.62070098 |
| 83 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.61932804 |
| 84 | positive regulation of isotype switching (GO:0045830) | 2.61275259 |
| 85 | regulation of tumor necrosis factor production (GO:0032680) | 2.60515683 |
| 86 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.60369628 |
| 87 | positive regulation of mast cell activation (GO:0033005) | 2.58814083 |
| 88 | leukocyte degranulation (GO:0043299) | 2.57679318 |
| 89 | positive regulation of granulocyte differentiation (GO:0030854) | 2.57267088 |
| 90 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.55689887 |
| 91 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.54904253 |
| 92 | lipoxygenase pathway (GO:0019372) | 2.53829383 |
| 93 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.52904502 |
| 94 | regulation of superoxide anion generation (GO:0032928) | 2.52230807 |
| 95 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.51816391 |
| 96 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.51344020 |
| 97 | regulation of granulocyte differentiation (GO:0030852) | 2.50548815 |
| 98 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 2.50212957 |
| 99 | oligosaccharide catabolic process (GO:0009313) | 2.49463368 |
| 100 | positive regulation of B cell activation (GO:0050871) | 2.49157607 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.17804445 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.52363631 |
| 3 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.86664906 |
| 4 | VDR_24763502_ChIP-Seq_THP-1_Human | 3.39515120 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.32311075 |
| 6 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 3.21207594 |
| 7 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.06754447 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.06426975 |
| 9 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.90363763 |
| 10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.64944178 |
| 11 | MYC_22102868_ChIP-Seq_BL_Human | 2.53678702 |
| 12 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.49565361 |
| 13 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.45719796 |
| 14 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.42971248 |
| 15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.42653380 |
| 16 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.40115890 |
| 17 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.34325749 |
| 18 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.31638120 |
| 19 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.30123285 |
| 20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.28619701 |
| 21 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.06345406 |
| 22 | MAF_26560356_Chip-Seq_TH1_Human | 2.04353144 |
| 23 | UTX_26944678_Chip-Seq_JUKART_Human | 2.01045292 |
| 24 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.01034059 |
| 25 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.00963080 |
| 26 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.00483906 |
| 27 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.99893841 |
| 28 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.97719978 |
| 29 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.88698612 |
| 30 | SPI1_23127762_ChIP-Seq_K562_Human | 1.87371931 |
| 31 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.87179975 |
| 32 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.83846315 |
| 33 | MYB_26560356_Chip-Seq_TH2_Human | 1.83800641 |
| 34 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.73722959 |
| 35 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.73473579 |
| 36 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.70499885 |
| 37 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.70015671 |
| 38 | GATA1_19941826_ChIP-Seq_K562_Human | 1.69840437 |
| 39 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68447218 |
| 40 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.66384496 |
| 41 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64606742 |
| 42 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.63301409 |
| 43 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.62697218 |
| 44 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.62200807 |
| 45 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.61021592 |
| 46 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60767064 |
| 47 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.58316101 |
| 48 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58082099 |
| 49 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.56493683 |
| 50 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.54606899 |
| 51 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.54053877 |
| 52 | MYB_26560356_Chip-Seq_TH1_Human | 1.53514651 |
| 53 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.53071693 |
| 54 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.52816080 |
| 55 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.50854137 |
| 56 | GATA1_22025678_ChIP-Seq_K562_Human | 1.48889639 |
| 57 | MAF_26560356_Chip-Seq_TH2_Human | 1.47575637 |
| 58 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.46544773 |
| 59 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.46168522 |
| 60 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.43306102 |
| 61 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.42675230 |
| 62 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.42252308 |
| 63 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.41966004 |
| 64 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.39660897 |
| 65 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.39497088 |
| 66 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.38821501 |
| 67 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.36157683 |
| 68 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.34693182 |
| 69 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.34478258 |
| 70 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.32711314 |
| 71 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.29611237 |
| 72 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.27430467 |
| 73 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.26766467 |
| 74 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.23635602 |
| 75 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.23163332 |
| 76 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21551827 |
| 77 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.19858516 |
| 78 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.19439919 |
| 79 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.18243968 |
| 80 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.18235193 |
| 81 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17366997 |
| 82 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.15856272 |
| 83 | GATA2_19941826_ChIP-Seq_K562_Human | 1.15120074 |
| 84 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10260589 |
| 85 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.07484882 |
| 86 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02897487 |
| 87 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02359197 |
| 88 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.00953872 |
| 89 | * P68_20966046_ChIP-Seq_HELA_Human | 1.00804409 |
| 90 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00387082 |
| 91 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98676918 |
| 92 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.97349953 |
| 93 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.96974076 |
| 94 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.96541679 |
| 95 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95814363 |
| 96 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.95661103 |
| 97 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.93823641 |
| 98 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.93639819 |
| 99 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.91272586 |
| 100 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.89045527 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003436_decreased_susceptibility_to | 5.42635128 |
| 2 | MP0003303_peritoneal_inflammation | 4.23035649 |
| 3 | MP0005058_abnormal_lysosome_morphology | 3.50356495 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.10631296 |
| 5 | MP0005397_hematopoietic_system_phenotyp | 3.01485436 |
| 6 | MP0001545_abnormal_hematopoietic_system | 3.01485436 |
| 7 | MP0002419_abnormal_innate_immunity | 2.94423009 |
| 8 | MP0003172_abnormal_lysosome_physiology | 2.85577922 |
| 9 | MP0005025_abnormal_response_to | 2.79792916 |
| 10 | MP0002148_abnormal_hypersensitivity_rea | 2.74184246 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.67686177 |
| 12 | MP0005464_abnormal_platelet_physiology | 2.63846388 |
| 13 | MP0009278_abnormal_bone_marrow | 2.59664287 |
| 14 | MP0001533_abnormal_skeleton_physiology | 2.59610753 |
| 15 | MP0003300_gastrointestinal_ulcer | 2.58927030 |
| 16 | MP0003724_increased_susceptibility_to | 2.47621218 |
| 17 | MP0009785_altered_susceptibility_to | 2.29746902 |
| 18 | MP0002396_abnormal_hematopoietic_system | 2.14664899 |
| 19 | MP0002420_abnormal_adaptive_immunity | 2.11612588 |
| 20 | MP0001790_abnormal_immune_system | 2.11092338 |
| 21 | MP0005387_immune_system_phenotype | 2.11092338 |
| 22 | MP0001819_abnormal_immune_cell | 2.10412121 |
| 23 | MP0006082_CNS_inflammation | 2.09782567 |
| 24 | MP0003656_abnormal_erythrocyte_physiolo | 2.01167936 |
| 25 | MP0009840_abnormal_foam_cell | 1.99005079 |
| 26 | MP0002452_abnormal_antigen_presenting | 1.98935241 |
| 27 | MP0001800_abnormal_humoral_immune | 1.97527175 |
| 28 | MP0000465_gastrointestinal_hemorrhage | 1.96216117 |
| 29 | MP0003191_abnormal_cellular_cholesterol | 1.93419227 |
| 30 | MP0002723_abnormal_immune_serum | 1.92408331 |
| 31 | MP0010155_abnormal_intestine_physiology | 1.90140332 |
| 32 | MP0003075_altered_response_to | 1.80307124 |
| 33 | MP0001853_heart_inflammation | 1.75161040 |
| 34 | MP0005671_abnormal_response_to | 1.59925824 |
| 35 | MP0000716_abnormal_immune_system | 1.57588254 |
| 36 | MP0002398_abnormal_bone_marrow | 1.56986406 |
| 37 | MP0001845_abnormal_inflammatory_respons | 1.54558032 |
| 38 | MP0009764_decreased_sensitivity_to | 1.52959474 |
| 39 | MP0000604_amyloidosis | 1.52448825 |
| 40 | MP0004808_abnormal_hematopoietic_stem | 1.50710532 |
| 41 | MP0002405_respiratory_system_inflammati | 1.50609126 |
| 42 | MP0000685_abnormal_immune_system | 1.48042334 |
| 43 | MP0002998_abnormal_bone_remodeling | 1.44270673 |
| 44 | MP0004947_skin_inflammation | 1.43453558 |
| 45 | MP0008469_abnormal_protein_level | 1.41486701 |
| 46 | MP0000343_altered_response_to | 1.39137251 |
| 47 | MP0002429_abnormal_blood_cell | 1.37825743 |
| 48 | MP0000689_abnormal_spleen_morphology | 1.33285278 |
| 49 | MP0002139_abnormal_hepatobiliary_system | 1.32774677 |
| 50 | MP0002722_abnormal_immune_system | 1.31986694 |
| 51 | MP0005451_abnormal_body_composition | 1.31789032 |
| 52 | MP0005390_skeleton_phenotype | 1.31751765 |
| 53 | MP0002009_preneoplasia | 1.29431994 |
| 54 | MP0003448_altered_tumor_morphology | 1.26353426 |
| 55 | MP0009333_abnormal_splenocyte_physiolog | 1.23486370 |
| 56 | MP0003763_abnormal_thymus_physiology | 1.19601892 |
| 57 | MP0001851_eye_inflammation | 1.18670591 |
| 58 | MP0005166_decreased_susceptibility_to | 1.17509497 |
| 59 | MP0003828_pulmonary_edema | 1.16840138 |
| 60 | MP0003183_abnormal_peptide_metabolism | 1.15772216 |
| 61 | MP0008004_abnormal_stomach_pH | 1.14686762 |
| 62 | MP0005666_abnormal_adipose_tissue | 1.10756060 |
| 63 | MP0001663_abnormal_digestive_system | 1.08068915 |
| 64 | MP0004185_abnormal_adipocyte_glucose | 1.06908859 |
| 65 | MP0003806_abnormal_nucleotide_metabolis | 1.02985423 |
| 66 | MP0000858_altered_metastatic_potential | 1.00397329 |
| 67 | MP0002166_altered_tumor_susceptibility | 1.00097526 |
| 68 | MP0009763_increased_sensitivity_to | 0.96729682 |
| 69 | MP0003453_abnormal_keratinocyte_physiol | 0.94115196 |
| 70 | MP0009765_abnormal_xenobiotic_induced | 0.93759433 |
| 71 | MP0009379_abnormal_foot_pigmentation | 0.93707726 |
| 72 | MP0004510_myositis | 0.92241186 |
| 73 | MP0003866_abnormal_defecation | 0.91647062 |
| 74 | MP0004147_increased_porphyrin_level | 0.90753935 |
| 75 | MP0001873_stomach_inflammation | 0.89538583 |
| 76 | MP0004782_abnormal_surfactant_physiolog | 0.89418168 |
| 77 | MP0005535_abnormal_body_temperature | 0.88231426 |
| 78 | MP0003329_amyloid_beta_deposits | 0.87063608 |
| 79 | MP0008260_abnormal_autophagy | 0.83133223 |
| 80 | MP0005164_abnormal_response_to | 0.81242192 |
| 81 | MP0002877_abnormal_melanocyte_morpholog | 0.80386104 |
| 82 | MP0000703_abnormal_thymus_morphology | 0.80085856 |
| 83 | MP0005165_increased_susceptibility_to | 0.78940388 |
| 84 | MP0001764_abnormal_homeostasis | 0.77871613 |
| 85 | MP0000490_abnormal_crypts_of | 0.76764275 |
| 86 | MP0003795_abnormal_bone_structure | 0.76600025 |
| 87 | MP0002132_abnormal_respiratory_system | 0.76040694 |
| 88 | MP0002933_joint_inflammation | 0.73525146 |
| 89 | MP0005319_abnormal_enzyme/_coenzyme | 0.70409615 |
| 90 | MP0000249_abnormal_blood_vessel | 0.69585772 |
| 91 | MP0002006_tumorigenesis | 0.69278983 |
| 92 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.69028804 |
| 93 | MP0009115_abnormal_fat_cell | 0.68013702 |
| 94 | MP0005381_digestive/alimentary_phenotyp | 0.65924348 |
| 95 | MP0002019_abnormal_tumor_incidence | 0.65167754 |
| 96 | MP0005310_abnormal_salivary_gland | 0.63463497 |
| 97 | MP0010307_abnormal_tumor_latency | 0.62592695 |
| 98 | MP0005334_abnormal_fat_pad | 0.61967054 |
| 99 | MP0002971_abnormal_brown_adipose | 0.59606153 |
| 100 | MP0009931_abnormal_skin_appearance | 0.59583305 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glycolipid metabolism (HP:0010969) | 4.91323593 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.91323593 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.91323593 |
| 4 | Recurrent abscess formation (HP:0002722) | 4.48375356 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 4.31729475 |
| 6 | Abnormality of macrophages (HP:0004311) | 4.09395692 |
| 7 | Dysostosis multiplex (HP:0000943) | 4.05812864 |
| 8 | Petechiae (HP:0000967) | 4.00273169 |
| 9 | Prolonged bleeding time (HP:0003010) | 3.99822163 |
| 10 | Eczematoid dermatitis (HP:0000976) | 3.95985654 |
| 11 | Vacuolated lymphocytes (HP:0001922) | 3.92479151 |
| 12 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.91184656 |
| 13 | Myositis (HP:0100614) | 3.88594768 |
| 14 | Panhypogammaglobulinemia (HP:0003139) | 3.76031687 |
| 15 | Agammaglobulinemia (HP:0004432) | 3.74674569 |
| 16 | Increased cerebral lipofuscin (HP:0011813) | 3.67786974 |
| 17 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.55519417 |
| 18 | Autoimmune thrombocytopenia (HP:0001973) | 3.45618253 |
| 19 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.44509768 |
| 20 | Obstructive lung disease (HP:0006536) | 3.43440499 |
| 21 | Chronic obstructive pulmonary disease (HP:0006510) | 3.43440499 |
| 22 | Recurrent viral infections (HP:0004429) | 3.41588999 |
| 23 | Systemic lupus erythematosus (HP:0002725) | 3.38314059 |
| 24 | Increased IgE level (HP:0003212) | 3.28781721 |
| 25 | Recurrent fungal infections (HP:0002841) | 3.26082312 |
| 26 | Stomatitis (HP:0010280) | 3.18252252 |
| 27 | Acute lymphatic leukemia (HP:0006721) | 3.08614921 |
| 28 | Mediastinal lymphadenopathy (HP:0100721) | 3.07010999 |
| 29 | Recurrent skin infections (HP:0001581) | 3.04495470 |
| 30 | Epistaxis (HP:0000421) | 3.01970344 |
| 31 | Colitis (HP:0002583) | 3.01364347 |
| 32 | Recurrent cutaneous fungal infections (HP:0011370) | 2.98993471 |
| 33 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.98993471 |
| 34 | Cellulitis (HP:0100658) | 2.97747282 |
| 35 | Purpura (HP:0000979) | 2.95487547 |
| 36 | Thrombocytosis (HP:0001894) | 2.95457855 |
| 37 | Meningitis (HP:0001287) | 2.92458922 |
| 38 | Thoracic kyphosis (HP:0002942) | 2.87881977 |
| 39 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.84138751 |
| 40 | Increased serum ferritin (HP:0003281) | 2.81685361 |
| 41 | Orchitis (HP:0100796) | 2.79654593 |
| 42 | Encephalitis (HP:0002383) | 2.76874412 |
| 43 | Inflammation of the large intestine (HP:0002037) | 2.75447407 |
| 44 | Hepatosplenomegaly (HP:0001433) | 2.75183781 |
| 45 | Abnormality of the prostate (HP:0008775) | 2.72120132 |
| 46 | Gastrointestinal inflammation (HP:0004386) | 2.69699045 |
| 47 | Viral hepatitis (HP:0006562) | 2.62260708 |
| 48 | Interstitial pulmonary disease (HP:0006530) | 2.62038063 |
| 49 | Polygenic inheritance (HP:0010982) | 2.59110614 |
| 50 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.54833386 |
| 51 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.54833386 |
| 52 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.54833386 |
| 53 | Osteomyelitis (HP:0002754) | 2.54669037 |
| 54 | Acute myeloid leukemia (HP:0004808) | 2.54140887 |
| 55 | Autoimmune hemolytic anemia (HP:0001890) | 2.52698984 |
| 56 | Abnormality of T cell physiology (HP:0011840) | 2.49792504 |
| 57 | Hypergammaglobulinemia (HP:0010702) | 2.46739914 |
| 58 | Abnormality of iron homeostasis (HP:0011031) | 2.46337664 |
| 59 | Urticaria (HP:0001025) | 2.45242690 |
| 60 | Mucopolysacchariduria (HP:0008155) | 2.44371755 |
| 61 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.44371755 |
| 62 | Spontaneous hematomas (HP:0007420) | 2.43103976 |
| 63 | Prostate neoplasm (HP:0100787) | 2.39083390 |
| 64 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.36161014 |
| 65 | Abnormality of B cell number (HP:0010975) | 2.35232544 |
| 66 | Retrobulbar optic neuritis (HP:0100654) | 2.32530962 |
| 67 | Optic neuritis (HP:0100653) | 2.32530962 |
| 68 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.30807376 |
| 69 | Gingivitis (HP:0000230) | 2.30292803 |
| 70 | Hypertensive crisis (HP:0100735) | 2.30088013 |
| 71 | Disinhibition (HP:0000734) | 2.25572818 |
| 72 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.23660596 |
| 73 | Mutism (HP:0002300) | 2.23284364 |
| 74 | Loss of speech (HP:0002371) | 2.21562020 |
| 75 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.20452044 |
| 76 | Hematochezia (HP:0002573) | 2.19280132 |
| 77 | B lymphocytopenia (HP:0010976) | 2.16048224 |
| 78 | Abnormality of complement system (HP:0005339) | 2.15326218 |
| 79 | Granulocytopenia (HP:0001913) | 2.14755177 |
| 80 | Vasculitis (HP:0002633) | 2.13593370 |
| 81 | Amyloidosis (HP:0011034) | 2.11378913 |
| 82 | Leukocytosis (HP:0001974) | 2.07321334 |
| 83 | Abnormality of the thoracic spine (HP:0100711) | 2.07049359 |
| 84 | Abnormal platelet function (HP:0011869) | 2.03963772 |
| 85 | Impaired platelet aggregation (HP:0003540) | 2.03963772 |
| 86 | Episodic fever (HP:0001954) | 2.02479772 |
| 87 | Pulmonary infiltrates (HP:0002113) | 2.01421585 |
| 88 | Increased IgM level (HP:0003496) | 2.01224151 |
| 89 | Gingival bleeding (HP:0000225) | 1.98666229 |
| 90 | Chronic otitis media (HP:0000389) | 1.97707868 |
| 91 | Abnormality of the periventricular white matter (HP:0002518) | 1.97553373 |
| 92 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.96710370 |
| 93 | Skin rash (HP:0000988) | 1.96578742 |
| 94 | Axonal loss (HP:0003447) | 1.95591363 |
| 95 | Polycythemia (HP:0001901) | 1.95524295 |
| 96 | Abnormality of the lumbar spine (HP:0100712) | 1.95113845 |
| 97 | Abnormality of T cells (HP:0002843) | 1.92461776 |
| 98 | Progressive neurologic deterioration (HP:0002344) | 1.91828663 |
| 99 | Hemoptysis (HP:0002105) | 1.88016490 |
| 100 | Stomach cancer (HP:0012126) | 1.84037554 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 4.05079146 |
| 2 | RIPK4 | 3.65946079 |
| 3 | PRPF4B | 3.57095747 |
| 4 | KIT | 3.43191198 |
| 5 | FES | 3.33303651 |
| 6 | ERN1 | 2.85185521 |
| 7 | TBK1 | 2.50675898 |
| 8 | MAP4K1 | 2.48397933 |
| 9 | MAP2K3 | 2.40817799 |
| 10 | MATK | 2.27468695 |
| 11 | MAP3K11 | 2.22487803 |
| 12 | BLK | 2.03573565 |
| 13 | TRIB3 | 1.91693673 |
| 14 | MAP3K14 | 1.90175354 |
| 15 | TYK2 | 1.86308565 |
| 16 | TAOK2 | 1.83518282 |
| 17 | TNK2 | 1.82290245 |
| 18 | MAP3K13 | 1.73161175 |
| 19 | BTK | 1.72128035 |
| 20 | CDK6 | 1.70043718 |
| 21 | IKBKB | 1.64228250 |
| 22 | FLT3 | 1.63518698 |
| 23 | CSF1R | 1.63347725 |
| 24 | BMPR2 | 1.62869392 |
| 25 | IRAK3 | 1.61891069 |
| 26 | ZAP70 | 1.60280137 |
| 27 | TEC | 1.57083749 |
| 28 | IKBKE | 1.51483735 |
| 29 | GRK6 | 1.49494318 |
| 30 | SYK | 1.46770499 |
| 31 | JAK3 | 1.41797408 |
| 32 | TESK2 | 1.39585527 |
| 33 | KDR | 1.34518587 |
| 34 | LYN | 1.27731437 |
| 35 | MAP3K3 | 1.23325387 |
| 36 | MAP3K1 | 1.21618591 |
| 37 | MAP3K6 | 1.19389994 |
| 38 | IRAK4 | 1.18058462 |
| 39 | HCK | 1.17495909 |
| 40 | MOS | 1.16756369 |
| 41 | GRK7 | 1.15458937 |
| 42 | TAOK1 | 1.12141132 |
| 43 | CDK4 | 1.12040866 |
| 44 | PIM2 | 1.12022826 |
| 45 | RPS6KA4 | 1.08833139 |
| 46 | TGFBR2 | 1.04715815 |
| 47 | CSK | 1.04566551 |
| 48 | ABL2 | 1.04222487 |
| 49 | EEF2K | 1.03753557 |
| 50 | BCKDK | 1.00635761 |
| 51 | PKN2 | 0.95813643 |
| 52 | JAK2 | 0.93657448 |
| 53 | LCK | 0.91425708 |
| 54 | ITK | 0.88328947 |
| 55 | TXK | 0.88254671 |
| 56 | MAP2K2 | 0.86777852 |
| 57 | LRRK2 | 0.83971738 |
| 58 | HIPK2 | 0.81013052 |
| 59 | PDPK1 | 0.76474503 |
| 60 | TAOK3 | 0.76412116 |
| 61 | SCYL2 | 0.75278715 |
| 62 | MARK2 | 0.69128289 |
| 63 | PDK1 | 0.68372542 |
| 64 | PIM1 | 0.67112120 |
| 65 | FGR | 0.65624350 |
| 66 | MAPK15 | 0.64164220 |
| 67 | ARAF | 0.64144134 |
| 68 | RPS6KL1 | 0.63661576 |
| 69 | RPS6KC1 | 0.63661576 |
| 70 | JAK1 | 0.59480073 |
| 71 | CDC42BPA | 0.57406583 |
| 72 | IRAK1 | 0.56118656 |
| 73 | BMX | 0.55876282 |
| 74 | MAPK4 | 0.51451540 |
| 75 | STK10 | 0.51266848 |
| 76 | TRPM7 | 0.51263346 |
| 77 | CDK19 | 0.50983975 |
| 78 | RPS6KA6 | 0.49281081 |
| 79 | SIK3 | 0.48156378 |
| 80 | RPS6KA2 | 0.46771389 |
| 81 | MAP3K5 | 0.46208321 |
| 82 | MAPK3 | 0.44149851 |
| 83 | PRKCQ | 0.40119612 |
| 84 | RIPK1 | 0.39314589 |
| 85 | GSK3A | 0.38735876 |
| 86 | MARK3 | 0.38312978 |
| 87 | RET | 0.37597311 |
| 88 | MAP3K8 | 0.37564624 |
| 89 | IRAK2 | 0.36645988 |
| 90 | ABL1 | 0.36552669 |
| 91 | TGFBR1 | 0.35733126 |
| 92 | DDR2 | 0.35647980 |
| 93 | MAP3K7 | 0.33485563 |
| 94 | MAPK12 | 0.31532136 |
| 95 | MAP2K6 | 0.31130916 |
| 96 | TTN | 0.30955162 |
| 97 | CHUK | 0.30022493 |
| 98 | MAPKAPK2 | 0.29058466 |
| 99 | FYN | 0.26976942 |
| 100 | PTK6 | 0.26625204 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 4.18392760 |
| 2 | Asthma_Homo sapiens_hsa05310 | 3.79744443 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 3.12639616 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.87722420 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 2.74621175 |
| 6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.43765684 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.33489346 |
| 8 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.28486144 |
| 9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.25293454 |
| 10 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.24463384 |
| 11 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.07207650 |
| 12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.01249688 |
| 13 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.99598520 |
| 14 | Malaria_Homo sapiens_hsa05144 | 1.97564346 |
| 15 | Tuberculosis_Homo sapiens_hsa05152 | 1.97347146 |
| 16 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.82627892 |
| 17 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.81756604 |
| 18 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.78119344 |
| 19 | Lysosome_Homo sapiens_hsa04142 | 1.76793407 |
| 20 | Pertussis_Homo sapiens_hsa05133 | 1.75243582 |
| 21 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.72374610 |
| 22 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.69646583 |
| 23 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.67263095 |
| 24 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.65424992 |
| 25 | Legionellosis_Homo sapiens_hsa05134 | 1.59851613 |
| 26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.58802660 |
| 27 | Influenza A_Homo sapiens_hsa05164 | 1.50543897 |
| 28 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.50472693 |
| 29 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.49864836 |
| 30 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.47618828 |
| 31 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.44949608 |
| 32 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.36670312 |
| 33 | Salmonella infection_Homo sapiens_hsa05132 | 1.32722984 |
| 34 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.29547618 |
| 35 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.27600129 |
| 36 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.26529679 |
| 37 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.22015082 |
| 38 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.20588494 |
| 39 | Viral myocarditis_Homo sapiens_hsa05416 | 1.20558813 |
| 40 | Phagosome_Homo sapiens_hsa04145 | 1.16049662 |
| 41 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.15807257 |
| 42 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.12635032 |
| 43 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.11547378 |
| 44 | Platelet activation_Homo sapiens_hsa04611 | 1.06894439 |
| 45 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.96527348 |
| 46 | Hepatitis B_Homo sapiens_hsa05161 | 0.96157121 |
| 47 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.93710192 |
| 48 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.91035927 |
| 49 | Measles_Homo sapiens_hsa05162 | 0.90265101 |
| 50 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.89470046 |
| 51 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.86623509 |
| 52 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.86251017 |
| 53 | Shigellosis_Homo sapiens_hsa05131 | 0.86006380 |
| 54 | Amoebiasis_Homo sapiens_hsa05146 | 0.85079318 |
| 55 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.82464680 |
| 56 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.81916736 |
| 57 | Hepatitis C_Homo sapiens_hsa05160 | 0.76025879 |
| 58 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.72285901 |
| 59 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.72018287 |
| 60 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.71920899 |
| 61 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.66095381 |
| 62 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.64106781 |
| 63 | Apoptosis_Homo sapiens_hsa04210 | 0.64042259 |
| 64 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.62372959 |
| 65 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.61337368 |
| 66 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.58932335 |
| 67 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.58855851 |
| 68 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.58694313 |
| 69 | Bladder cancer_Homo sapiens_hsa05219 | 0.57340094 |
| 70 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.54798489 |
| 71 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.52824796 |
| 72 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.52432859 |
| 73 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.51070956 |
| 74 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.48586917 |
| 75 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.47698805 |
| 76 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.46327644 |
| 77 | Ribosome_Homo sapiens_hsa03010 | 0.45471876 |
| 78 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.45172287 |
| 79 | HTLV-I infection_Homo sapiens_hsa05166 | 0.44993749 |
| 80 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.43550021 |
| 81 | Galactose metabolism_Homo sapiens_hsa00052 | 0.43020511 |
| 82 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.40540907 |
| 83 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.38438851 |
| 84 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.38152393 |
| 85 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.37588116 |
| 86 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.37312282 |
| 87 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.36243452 |
| 88 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.35120506 |
| 89 | Insulin resistance_Homo sapiens_hsa04931 | 0.32437443 |
| 90 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.30012863 |
| 91 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.29625885 |
| 92 | Prion diseases_Homo sapiens_hsa05020 | 0.28737352 |
| 93 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.28711269 |
| 94 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.27693417 |
| 95 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.26847225 |
| 96 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.25087890 |
| 97 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.24201715 |
| 98 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.23809325 |
| 99 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.23359256 |
| 100 | Endocytosis_Homo sapiens_hsa04144 | 0.22628783 |

